Effect of imatinib and nilotinib on lipopolysaccharide-induced acute lung injury during neutropenia recovery in a mouse model Source: Annual Congress 2012 - Lung injury, respiratory muscles and mechanical ventilation Year: 2012
Post-treatment with the heat shock protein 90 (hsp90) inhibitor, AUY-922, reduces lung hsp90 tyrosine (Y) phosphorylation and pulmonary inflammation in LPS-induced acute lung injury (ALI) in mice Source: Annual Congress 2013 –The role of hormones and cytokines in lung injury Year: 2013
Neutrophil elastase inhibitor sivelestat ameliorates gefitinib, naphthalene-induced acute pneumonitis in mice Source: International Congress 2015 – Novel insights into the pathobiology of acute lung injury Year: 2015
Acute lung injury as a possible adverse drug reaction related to gefitinib Source: Eur Respir J 2002 Jan 01;22(1):179-181 Year: 2003
Salmeterol prevents pneumonia and reduces biomarkers of inflammation/epithelial damage but not acute lung injury following oesophagectomy-the results of BALTI-prevention trial Source: Annual Congress 2013 –Acute lung injury: novel clinical and experimental insights Year: 2013
Dexamethasone in patients with acute lung injury from acute monocytic leukaemia Source: Eur Respir J 2012; 39: 648-653 Year: 2012
The effect of roflumilast on lipopolysaccharide-induced acute lung injury during neutropenia recovery in mice Source: Virtual Congress 2021 – Developments in biomarkers and treatment strategies for chronic lung diseases Year: 2021
Erythropoietin inhibits respiratory epithelial cell apoptosis in a model of acute lung injury Source: Eur Respir J 2009; 33: 1403-1414 Year: 2009
Pioglitazone attenuates endotoxin-induced acute lung injury by reducing neutrophil recruitment Source: Eur Respir J 2012; 40: 416-423 Year: 2012
Hsp90 binding inhibitors improve survival in a murine model of sepsis induced acute lung injury Source: Annual Congress 2006 - Novel pathogenic aspects of acute lung injury and acute respiratory distress syndrome (ARDS) Year: 2006
Prophylactic neutrophil elastase inhibitor (sivelestat) attenuates subsequent ventilator-induced lung injury Source: International Congress 2014 – ARDS, skeletal muscles, physiology and weaning Year: 2014
Usefulness of a selective neutrophil elastase inhibitor and a recombinant human soluble thrombomodulin in patients with ARDS and DIC Source: Annual Congress 2013 –Acute respiratory failure, ARDS and severe COPD exacerbations Year: 2013
Comparison of reducing effect on lung injury of dexamethasone and bosentan in acute lung injury: An experimental study Source: International Congress 2014 – Experimental models in acute lung injury Year: 2014
AZD7624, an inhaled p38 inhibitor for COPD, attenuates lung and systemic inflammation after LPS Challenge in humans Source: International Congress 2015 – Advances in the future treatment of COPD Year: 2015
Effects of N-acetylcysteine in lipopolysaccharide-induced acute lung injury in the rat: Treatment after acute lung injury Source: Annual Congress 2011 - Mechanical ventilation and lung injury: new advances Year: 2011
The effect of dasatinib, a novel tyrosine kinase inhibitor, on the regression of pulmonary fibrosis in mice Source: International Congress 2014 – New and old players in fibrotic lung disease Year: 2014
Effects of autophagy on LPS-induced lung inflammation and acute lung injury (ALI) in vitro and in vivo Source: International Congress 2018 – Role of microbial exposure and inflammation in lung injury Year: 2018
Effect of sivelestat in patients with acute lung injury Source: Eur Respir J 2006; 28: Suppl. 50, 347s Year: 2006
LATE-BREAKING ABSTRACT: Activation of MTOR in pulmonary epithelium promotes LPS-induced acute lung injury Source: International Congress 2016 – Novel mechanisms and therapeutic targets in acute and chronic inflammatory disease Year: 2016
Gabexate mesilate attenuates ischemia-reperfusion injury of lung grafts via the inhibition of neutrophil activation Source: Annual Congress 2005 - Recent advances in graft dysfunction after lung transplantation Year: 2005